Assessing the impact on intestinal microbiome and clinical outcomes of antibiotherapy optimisation strategies in haematopoietic stem cell transplant recipients: study protocol for the prospective multicentre OptimBioma study

INTRODUCTION: Haematopoietic stem cell transplantation (HSCT) is a life-saving treatment for a number of haematological diseases. Graft versus host disease (GVHD) is its main complication and hampers survival. There is strong evidence that intestinal microbiota diversity of the recipient may increas...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiménez-Jorge, Silvia, Labrador-Herrera, Gema, Rosso-Fernández, Clara M, Rodríguez-Torres, Nancy, Pachón-Ibáñez, María Eugenia, Smani, Younes, Márquez-Malaver, Francisco José, Limón Ramos, Carmen, Solano, Carlos, Vázquez-López, Lourdes, Kwon, Mi, Mora Barrios, Joan Manuel, Aguilar-Guisado, Manuela, Espigado, Ildefonso
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Haematology (Incl Blood Transfusion)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375627/
https://www.ncbi.nlm.nih.gov/pubmed/32690735
http://dx.doi.org/10.1136/bmjopen-2019-034570

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375627/
https://www.ncbi.nlm.nih.gov/pubmed/32690735
http://dx.doi.org/10.1136/bmjopen-2019-034570

Ejemplares similares